Polymorphisms at the ANRIL gene are associated with the risks of many human diseases, including malignancy, cardiovascular disease, bone mass, obesity, and type 2 diabetes [15]. This evidence concerns the gene CDKN2B-AS1 and obesity due to melanocortin 4 receptor deficiency.